The Royal North Shore Hospital is a major public teaching hospital in Sydney, Australia, located in St Leonards. It serves as a teaching hospital for Sydney Medical School at the University of Sydney and has approximately 700 beds. It is the referral hospital for Northern Sydney.

There are 713 beds in Royal North Shore Hospital.

During the past decade, Royal North Shore Hospital conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 54 clinical trials were completed, i.e. on average, 30.7% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 32 clinical trials were completed. i.e. 41.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal North Shore Hospital" #1 sponsor was "Royal North Shore Hospital" with 15 trials, followed by "University of Sydney" with 13 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 11 trials sponsored, "Trans Tasman Radiation Oncology Group" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 220 different institutions and companies that sponsored additional 144 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal North Shore Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 22 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 7 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Medical Research Institute of New Zealand" with 5 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator. Other collaborators include 301 different institutions and companies that were collaborators in the rest 230 trials.

According to Clinical.Site data, the most researched conditions in "Royal North Shore Hospital" are "Prostate Cancer" (10 trials), "Breast Cancer" (8 trials), "Fallopian Tube Cancer" (7 trials), "Coronary Artery Disease" (6 trials) and "Critical Illness" (6 trials). Many other conditions were trialed in "Royal North Shore Hospital" in a lesser frequency.

Most popular intervention types in "Royal North Shore Hospital" are "Drug" (196 trials), "Other" (41 trials), "Device" (32 trials), "Radiation" (29 trials) and "Procedure" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Cisplatin" (8 trials), "Carboplatin" (7 trials), "Radiotherapy" (7 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Royal North Shore Hospital" are 249 trials for "All" genders, 21 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 108 active trials in "Royal North Shore Hospital". 2 are not yet recruiting, 60 are recruiting, 43 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 128 completed trials in Royal North Shore Hospital, undefined suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Royal North Shore Hospital, 14 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 52 trials that are defined as “Not Applicable".